Medizinisches Laboratorium med. Bernhard Thiele Im Institut für Immunologie und Genetik

Official name: Medizinisches Laboratorium Dr. med. Bernhard Thiele Im Institut für Immunologie und Genetik

170 capabilities Accredited since January 2025 Verified May 2026 One of 3,056 in Germany

Details

Pfaffplatz 10
Kaiserslautern 67655 , Germany

Accreditation

Active DAkkS D-ML-13374-01-00
Unclaimed listing · Claim this lab

Specialises in human genetic testing combining molecular and cytogenetic analysis with virology and transfusion medicine services. Employs PCR-based large-amplicon sequencing and next-generation sequencing technologies on blood and DNA specimens for molecular genetic investigations.

Accreditation Details

Accreditation Body

DAkkS

Number

D-ML-13374-01-00

Status

Active

Since

29 January 2025

Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.

Download Scope PDF
170 capabilities

Send an Enquiry

Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.

Please select a test method from the list

Test Capabilities (170)

Standard Reference Description Category
(Customized Panel ABA) (Customized Panel ABA) Biocompatibility (ISO 10993)
(PROC-Gen [OMIM *612283]) (PROC-Gen [OMIM *612283]) Biocompatibility (ISO 10993)
(PROS1-Gen [OMIM *1768801) (PROS1-Gen [OMIM *1768801) Biocompatibility (ISO 10993)
(SERPINC1-Gen [OMIM *107300]) (SERPINC1-Gen [OMIM *107300]) Biocompatibility (ISO 10993)
(UGT1A1*28-, *6- Polymorphismus) (UGT1A1*28-, *6- Polymorphismus) Biocompatibility (ISO 10993)
(VWF-Gen [OMIM *613160]) (VWF-Gen [OMIM *613160]) Biocompatibility (ISO 10993)
32 Deletion 32 Deletion Biocompatibility (ISO 10993)
5-Fluorouracil-Toxizitäts-Panel 5-Fluorouracil-Toxizitäts-Panel Biocompatibility (ISO 10993)
AF4/MLL-Translokation t(4;11) AF4/MLL-Translokation t(4;11) Biocompatibility (ISO 10993)
Angeborener Chromosomensatz angeborener Chromosomensatz Biocompatibility (ISO 10993)
CCND1/IGH-Translokation CCND1/IGH-Translokation Biocompatibility (ISO 10993)
Chemokinrezeptor 5 (CCR5)-delta Chemokinrezeptor 5 (CCR5)-delta Biocompatibility (ISO 10993)
Erworbener Chromosomensatz erworbener Chromosomensatz Biocompatibility (ISO 10993)
FIP1L1-PDGFRA-Fusion FIP1L1-PDGFRA-Fusion Biocompatibility (ISO 10993)
FSAP [OMIM*603924] dbSNP FSAP [OMIM*603924] dbSNP Biocompatibility (ISO 10993)
H Bs-Antigen HBs-Antigen Biocompatibility (ISO 10993)
HLA-Antikörper (Spezifizierung) HLA-Antikörper (Spezifizierung) Biocompatibility (ISO 10993)
IGH/BCL2-Translokation IGH/BCL2-Translokation Biocompatibility (ISO 10993)
Nachweis spezifischer chromosomaler Nachweis spezifischer chromosomaler Biocompatibility (ISO 10993)
RH-System Rh-System Biocompatibility (ISO 10993)
Thrombophilie-Panel Thrombophilie-Panel Biocompatibility (ISO 10993)
cABL/BCR-Translokation cABL/BCR-Translokation Biocompatibility (ISO 10993)
del(4)(q12q12) del(4)(q12q12) Biocompatibility (ISO 10993)
r5121909548; F2 [OMIM *176930] r5121909548; F2 [OMIM *176930] Biocompatibility (ISO 10993)
r57080536; MTHFR [OMIM*607093] r57080536; MTHFR [OMIM*607093] Biocompatibility (ISO 10993)
t(11;14) t(11;14) Biocompatibility (ISO 10993)
t(9;22), qualitativ t(9;22), qualitativ Biocompatibility (ISO 10993)
t(9;22), quantitativ t(9;22), quantitativ Biocompatibility (ISO 10993)
(Zweifeld-Typisierung) (Zweifeld-Typisierung) Elemental Analysis
DPA1*, DPB1* DPA1*, DPB1* Elemental Analysis
DRB1*, DQA1*, DQB1* DRB1*, DQA1*, DQB1* Elemental Analysis
HLA-A*, B*, C* HLA-A*, B*, C* Elemental Analysis
Anti HBe Anti-HBe Food Safety Testing
Anti HCV Anti-HCV Food Safety Testing
Anti-HAV IgG Anti-HAV-IgG Food Safety Testing
CMV DNA CMV-DNA Food Safety Testing
EBV EBNA-1 IgG EBV Ebna-1-IgG Food Safety Testing
HBV DNA HBV-DNA Food Safety Testing
HCV RNA HCV-RNA Food Safety Testing
HIV RNA HIV-RNA Food Safety Testing
AKS AKS Hematology
ABO System ABO-System Immunology / Serology
Anti HBC -IgG Anti HBC -IgG Immunology / Serology
CMV IgG + IgM Antikörper CMV IgG + IgM Antikörper Immunology / Serology
H1V1/2 Antikörper / p24-Antigen H1V1/2 Antikörper / p24-Antigen Immunology / Serology
HIV-Wirtsresistenz HIV-Wirtsresistenz Immunology / Serology
HLA-Antikörper (Crossmatch) HLA-Antikörper (Crossmatch) Immunology / Serology
HTLV1/11 Antikörper HTLV1/11 Antikörper Immunology / Serology
Kell-Antigen Kell-Antigen Immunology / Serology
Rubella-Virus IgG Antikörper Rubella-Virus IgG Antikörper Immunology / Serology
anti-HBs quantitativ anti-HBs quantitativ Immunology / Serology
freie irreguläre Antikörper freie irreguläre Antikörper Immunology / Serology
(CFTR-Gen [OMIM *6024211) (CFTR-Gen [OMIM *6024211) Molecular Diagnostics / PCR
(FBN1-Gen [OMIM *134797]) (FBN1-Gen [OMIM *134797]) Molecular Diagnostics / PCR
(Gen-Panel mit 978 Genen) (Gen-Panel mit 978 Genen) Molecular Diagnostics / PCR
(MDS) (MDS) Molecular Diagnostics / PCR
(TP 53-Gen) (TP 53-Gen) Molecular Diagnostics / PCR
(in-house) (in-house) Molecular Diagnostics / PCR
*134820], GSN [OMIM *137350], LYZ [OMIM *1534501, OSMR [OMIM *134820], GSN [OMIM *137350], LYZ [OMIM *1534501, OSMR [OMIM Molecular Diagnostics / PCR
*136351], IDH1 [OMIM *1477001, IDH2 [OMIM *1476501, JAK2 [OMIM *136351], IDH1 [OMIM *1477001, IDH2 [OMIM *1476501, JAK2 [OMIM Molecular Diagnostics / PCR
*1389711, DDX41 [OMIM *6081701 *1389711, DDX41 [OMIM *6081701 Molecular Diagnostics / PCR
*1477961, KIT [OMIM *164920], NPM1 [OMIM *164040], NRAS *1477961, KIT [OMIM *164920], NPM1 [OMIM *164040], NRAS Molecular Diagnostics / PCR
*1513851, SETBP1 [OMIM *6110601, SF3B1 [OMIM *605590], SRSF2 *1513851, SETBP1 [OMIM *6110601, SF3B1 [OMIM *605590], SRSF2 Molecular Diagnostics / PCR
*1607101, MYH7 [OMIM *160760], NXN [OMIM *612895], PLN [OMIM *1607101, MYH7 [OMIM *160760], NXN [OMIM *612895], PLN [OMIM Molecular Diagnostics / PCR
*172405], PRDM16 [OMIM *172405], PRDM16 [OMIM Molecular Diagnostics / PCR
*300377], DSG2 [OMIM *125671], DSP [OMIM *1256471, EMD [OMIM *300377], DSG2 [OMIM *125671], DSP [OMIM *1256471, EMD [OMIM Molecular Diagnostics / PCR
*3003841, EYA4 [OMIM *603550], FHL1 [OMIM *300163], HFE [OMIM *3003841, EYA4 [OMIM *603550], FHL1 [OMIM *300163], HFE [OMIM Molecular Diagnostics / PCR
*600163], SGCD [OMIM *601411], TAZ [OMIM *300394], TCAP [OMIM *600163], SGCD [OMIM *601411], TAZ [OMIM *300394], TCAP [OMIM Molecular Diagnostics / PCR
*6044881, TMPO [OMIM *1883801, TNNI3 [OMIM *1910441, TNNT2 *6044881, TMPO [OMIM *1883801, TNNI3 [OMIM *1910441, TNNT2 Molecular Diagnostics / PCR
*605557], PSEN1 [OMIM *1043111, PSEN2 [OMIM *600759], RBM20 *605557], PSEN1 [OMIM *1043111, PSEN2 [OMIM *600759], RBM20 Molecular Diagnostics / PCR
*6095991, BAG3 [OMIM *6038831 *6095991, BAG3 [OMIM *6038831 Molecular Diagnostics / PCR
*6128391, TP53 [OMIM *1911701, U2AF1 [OMIM *1913171, ZRSR2 *6128391, TP53 [OMIM *1911701, U2AF1 [OMIM *1913171, ZRSR2 Molecular Diagnostics / PCR
*6136091 , LDB3 [OMIM *605906], LMNA [OMIM *150330], MYBPC3 *6136091 , LDB3 [OMIM *605906], LMNA [OMIM *150330], MYBPC3 Molecular Diagnostics / PCR
Amyloidose Amyloidose Molecular Diagnostics / PCR
Antithrombin-III-Mangel Antithrombin-III-Mangel Molecular Diagnostics / PCR
CNV FMR1 [OMIM*309550], AFF2 [OMIM*300806]; SNV, CNV Molecular Diagnostics / PCR
CSRP3 [OMIM *6008241 , DES CSRP3 [OMIM *6008241 , DES Molecular Diagnostics / PCR
Chimärismusanalyse Chimärismusanalyse Molecular Diagnostics / PCR
DNMT3A [OMIM *6027691 , EZH2 DNMT3A [OMIM *6027691 , EZH2 Molecular Diagnostics / PCR
Dilatative Kardiomyopathie (DCM) Dilatative Kardiomyopathie (DCM) Molecular Diagnostics / PCR
Entwicklungsstörungen Entwicklungsstörungen Molecular Diagnostics / PCR
Exomsequenzierung (SNV, CNV) Exomsequenzierung (SNV, CNV) Molecular Diagnostics / PCR
Familienanamnese. Familienanamnese. Molecular Diagnostics / PCR
HIV-RNA oder provirale DNA HIV-RNA oder provirale DNA Molecular Diagnostics / PCR
HNPCC/Lynch-Syndrom HNPCC/Lynch-Syndrom Molecular Diagnostics / PCR
HPV DNA HPV-DNA Molecular Diagnostics / PCR
Hereditäres Pankreaskarzinom Hereditäres Pankreaskarzinom Molecular Diagnostics / PCR
Mammakarzinom, metastasiertes Mammakarzinom, metastasiertes Molecular Diagnostics / PCR
Marfan Syndrom Marfan-Syndrom: FBN1, TGFBR1, TGFBR2, ACTA2, COL3A1, MYH11, MYLK, SMAD3, TGFB2 Molecular Diagnostics / PCR
Meulengracht- (Gilbert)-Syndrom Meulengracht- (Gilbert)-Syndrom Molecular Diagnostics / PCR
Myelodysplastisches Syndrom Myelodysplastisches Syndrom Molecular Diagnostics / PCR
Nachweis spezifischer Nachweis spezifischer Molecular Diagnostics / PCR
OMIM*612839, TP53 OMIM*612839, TP53 Molecular Diagnostics / PCR
Ovarialkarzinom (HBOC) Ovarialkarzinom (HBOC) Molecular Diagnostics / PCR
Pankreaskarzinom nach Pankreaskarzinom nach Molecular Diagnostics / PCR
Prostatakarzinom zur Prostatakarzinom zur Molecular Diagnostics / PCR
Protein C-Mangel Protein-C-Mangel Molecular Diagnostics / PCR
Protein S-Mangel Protein-S-Mangel Molecular Diagnostics / PCR
Risiko nach positiver Risiko nach positiver Molecular Diagnostics / PCR
Ungerichtete NGS-basierende Ungerichtete NGS-basierende Molecular Diagnostics / PCR
Vermutetes erhöhtes hereditäres Vermutetes erhöhtes hereditäres Molecular Diagnostics / PCR
Zystische Fibrose Zystische Fibrose Molecular Diagnostics / PCR
[OMIM *102573], ANKRD1 [OMIM [OMIM *102573], ANKRD1 [OMIM Molecular Diagnostics / PCR
[OMIM *109700], FGA [OMIM [OMIM *109700], FGA [OMIM Molecular Diagnostics / PCR
[OMIM *125660], DMD [OMIM [OMIM *125660], DMD [OMIM Molecular Diagnostics / PCR
[OMIM *164790], RUNX1 [OMIM [OMIM *164790], RUNX1 [OMIM Molecular Diagnostics / PCR
[OMIM *165360], CSF3R [OMIM [OMIM *165360], CSF3R [OMIM Molecular Diagnostics / PCR
[OMIM *191045], TPM1 [OMIM [OMIM *191045], TPM1 [OMIM Molecular Diagnostics / PCR
[OMIM *6008131, TET2 [OMIM [OMIM *6008131, TET2 [OMIM Molecular Diagnostics / PCR
[OMIM *600958], MYH6 [OMIM [OMIM *600958], MYH6 [OMIM Molecular Diagnostics / PCR
[OMIM *6015731, FLT3 [OMIM [OMIM *6015731, FLT3 [OMIM Molecular Diagnostics / PCR
[OMIM *613171], SCN5A [OMIM [OMIM *613171], SCN5A [OMIM Molecular Diagnostics / PCR
chromosomaler Regionen chromosomaler Regionen Molecular Diagnostics / PCR
metastasierendes Mammakarzinom metastasierendes Mammakarzinom Molecular Diagnostics / PCR
t(14;18) t(14;18) Molecular Diagnostics / PCR
t(15;17) t(15;17) Molecular Diagnostics / PCR
t(1;19) t(1;19) Molecular Diagnostics / PCR
t(8;21) t(8;21) Molecular Diagnostics / PCR
(ACTC1 [OMIM *1025401, ACTN2 (ACTC1 [OMIM *1025401, ACTN2 Other
(AP0A1 [OMIM *1076801, B2M (AP0A1 [OMIM *1076801, B2M Other
(ASXL1 [OMIM *612990], CBL (ASXL1 [OMIM *612990], CBL Other
(AT3 [OMIM *1073001 dbSNP (AT3 [OMIM *1073001 dbSNP Other
(DPYD (OMIM *612779), dbSNP (DPYD (OMIM *612779), dbSNP Other
(Detektion von 55 Mutationen (Detektion von 55 Mutationen Other
*1910101 , TTN [OMIM *188840], VCL [OMIM *1930651) *1910101 , TTN [OMIM *188840], VCL [OMIM *1930651) Other
*6006781 , PMS2 [OMIM *6002591, EPCAM [OMIM *1855351) *6006781 , PMS2 [OMIM *6002591, EPCAM [OMIM *1855351) Other
*6006781, PMS2 [OMIM *600259], EPCAM [OMIM *1855351) *6006781, PMS2 [OMIM *600259], EPCAM [OMIM *1855351) Other
*601743], TTR [OMIM *176300]) *601743], TTR [OMIM *176300]) Other
*6029541, STK11 [OMIM *6022161, TP53 [OMIM *1911701) *6029541, STK11 [OMIM *6022161, TP53 [OMIM *1911701) Other
HLA-Antikörper (Nachweis HLA-Antikörper (Nachweis Other
Inhibitoren) Inhibitoren) Other
SNV-Genotypisierung (Nachweis SNV-Genotypisierung (Nachweis Other
[OMIM *300028]) [OMIM *300028]) Other
[OMIM *6001851) [OMIM *6001851) Other
[OMIM *602421]) [OMIM *602421]) Other
[OMIM*173360] dbSNP r52227631, rs587776796) [OMIM*173360] dbSNP r52227631, rs587776796) Other
den Genen DNMT3A, FLT3, IDH1, IDH2, KIT, and NPM1) den Genen DNMT3A, FLT3, IDH1, IDH2, KIT, and NPM1) Other
lnhibitoren) lnhibitoren) Other
r53918290, rs55886062, rs56038477, rs67376798, rs72549309 und rs75017182) r53918290, rs55886062, rs56038477, rs67376798, rs72549309 und rs75017182) Other
(BRCA1 [OMIM *1137051, BRCA2 (BRCA1 [OMIM *1137051, BRCA2 Spectroscopy (XRF, ICP, AAS)
(FBN1-Gen [OMIM *1347971) (FBN1-Gen [OMIM *1347971) Spectroscopy (XRF, ICP, AAS)
(MLH1 [OMIM *120436] , MSH2 (MLH1 [OMIM *120436] , MSH2 Spectroscopy (XRF, ICP, AAS)
(PROC-Gen [OMIM *6122831) (PROC-Gen [OMIM *6122831) Spectroscopy (XRF, ICP, AAS)
(VWF-Gen [OMIM *6131601) (VWF-Gen [OMIM *6131601) Spectroscopy (XRF, ICP, AAS)
*6058821, CDH1 [OMIM *1920901 *6058821, CDH1 [OMIM *1920901 Spectroscopy (XRF, ICP, AAS)
*6093091, MSH6 [OMIM *600678], PMS2 [OMIM *6002591 , PTEN *6093091, MSH6 [OMIM *600678], PMS2 [OMIM *6002591 , PTEN Spectroscopy (XRF, ICP, AAS)
+604373], PALB2 [OMIM *6103551, RAD51C [OMIM *6027741, ATM +604373], PALB2 [OMIM *6103551, RAD51C [OMIM *6027741, ATM Spectroscopy (XRF, ICP, AAS)
1. Rezidiv eines Ovarialkarzinoms 1. Rezidiv eines Ovarialkarzinoms Spectroscopy (XRF, ICP, AAS)
2. HER2-negatives primäres 2. HER2-negatives primäres Spectroscopy (XRF, ICP, AAS)
EPCAM [OMIM *1855351, MLH1 EPCAM [OMIM *1855351, MLH1 Spectroscopy (XRF, ICP, AAS)
Fragmentlängen-Analyse Fragmentlängen-Analyse Spectroscopy (XRF, ICP, AAS)
Gerichtete NGS-Panel-Analyse Gerichtete NGS-Panel-Analyse Spectroscopy (XRF, ICP, AAS)
Gezielte Kopienzahlanalyse Gezielte Kopienzahlanalyse Spectroscopy (XRF, ICP, AAS)
Hereditäres Mamma-/ Hereditäres Mamma-/ Spectroscopy (XRF, ICP, AAS)
MYH11/CBFB-Translokation MYH11/CBFB-Translokation Spectroscopy (XRF, ICP, AAS)
Mamma-/Ovarialkarzinom Mamma-/Ovarialkarzinom Spectroscopy (XRF, ICP, AAS)
PBX1/E2A-Translokation PBX1/E2A-Translokation Spectroscopy (XRF, ICP, AAS)
PML/RARA-Translokation PML/RARA-Translokation Spectroscopy (XRF, ICP, AAS)
RUNX1/RUNX1T1-Translokation RUNX1/RUNX1T1-Translokation Spectroscopy (XRF, ICP, AAS)
Zystische Fibrose (CFTR-Gen Zystische Fibrose (CFTR-Gen Spectroscopy (XRF, ICP, AAS)
[OMIM *1204361, MSH2 [OMIM [OMIM *1204361, MSH2 [OMIM Spectroscopy (XRF, ICP, AAS)
[OMIM *6001851 , CHEK2 [OMIM [OMIM *6001851 , CHEK2 [OMIM Spectroscopy (XRF, ICP, AAS)
[OMIM *6017281, RAD51D [OMIM [OMIM *6017281, RAD51D [OMIM Spectroscopy (XRF, ICP, AAS)
[OMIM *6075851, BRIP1 [OMIM [OMIM *6075851, BRIP1 [OMIM Spectroscopy (XRF, ICP, AAS)
[OMIM *6093091 , MSH6 [OMIM [OMIM *6093091 , MSH6 [OMIM Spectroscopy (XRF, ICP, AAS)
[OMIM *609309], MSH6 [OMIM [OMIM *609309], MSH6 [OMIM Spectroscopy (XRF, ICP, AAS)
fortgeschrittenes Ovarialkarzinom, metastasiertes und HER2-negatives fortgeschrittenes Ovarialkarzinom, metastasiertes und HER2-negatives Spectroscopy (XRF, ICP, AAS)
EBV - VCA - IgG EBV VCA IgG Sterility Testing
EBV - VCA - IgM EBV VCA IgM Sterility Testing
inv(16) t(15;17), BFB/MYH 11inv(16) Sterility Testing
Report incorrect or outdated information
0 labs selected
Compare